(S)-2-Amino-3-((1S,2S)-2-di-(tert-butoxycarbonyl)amino-cyclopropyl)-propionic acid tert-butyl ester
To a solution of 8 (0.29 g, 0.52 mmol), in THF (5.5 ml), was added aqueous citric acid (2.70 ml, 15 % solution) dropwise at room temperature. The mixture was then stirred rapidly for 1.5 hours, followed by dilution with ethyl acetate (100 ml), washing with saturated sodium hydrogen carbonate (100 ml), then further extraction with ethyl acetate (100 ml). Organic fractions were combined and dried over magnesium sulfate, followed by removal of solvents in vacuo. The crude mixture was then purified by column chromatography (ethyl acetate eluent), to afford the desired amine 9 (0.173 g, 84 %) as a clear oil; [α] 23 D 26.8 (c 1.34, CHCl 3 ); ν max /cm -1 (film) 3403, 2979, 2933, 1785, 1733, 1367, 1282, 1254, 1159, 1118, 852, 752 
N-CBz-L-alanine-(S)-2-Amino-3-((1S,2S)-2-di-(tert-butoxycarbonyl)amino-
cyclopropyl)-propionic acid tert-butyl ester H N CO 2 t Bu NBoc 2 O CBzHN
10
To a mixture of DCC (33 mg, 0.16 mmol) and HOBt (43 mg, 0.32 mmol) in DMF (1 ml), was added a solution of amine 9 (32 mg, 0.08 mmol) and N-CBz-Ala (36 mg, S2 0.16 mmol) in DMF (1 ml), followed by further washing with DMF (0.5 ml). The mixture was then stirred at room temperature for 1 hour. DMF was removed at high vacuum (warm water bath), followed by addition of ether (3 ml) and filtration of the urea by-product. 
N-CBz-L-alanine-(S)-2-Amino-3-((1R
,
11
To a stirred solution of amino acid 10 (200 mg, 0.33 mmol) in dichloromethane (3.70 ml) at 0 °C was added TFA (3.70 ml) dropwise, and the mixture was placed in a fridge (approx 15 ºC)
for 20 h. Solvents were removed in vacuo, and the mixture was diluted with distilled water (25 ml), and washed with ether (25 ml). Aqueous fractions were concentrated in vacuo, and the residue was then freeze dried to afford the desired amine salt 11 (0.137 g, 90 %). This material was used directly in the next step without further purification. To a cooled solution of β-lactone 19 (0.14 g, 0.59 mmol) in dichloromethane (4 ml) at 0 °C, was added TFA dropwise (4 ml). The mixture was then stirred at this temperature for 15 hours, after which solvents were removed in vacuo, and the residue azeotroped from toluene (4 ml). After further concentration the mixture was then purified by column chromatography (9 CHCl 3 : 1 MeOH : 0.1 AcOH eluent), to afford acid 3 (0.92 g, 90 %) as a clear oil. This material was used directly in the next step.
S3 (2R,3S)-3-((S)-sec-Butyl)-4-oxo-oxetane-2-carboxylic acid tert-butyl ester

N-CBz belactosin A
To a cooled solution of β-lactone 3 (36 mg, 0.21 mmol) in CH 2 Cl 2 (2.30 ml) at 0 ˚C was added distilled water (2.30 ml), then HOBt (0.114 g, 0.84 mmol) and EDCI (81 mg, 0.42 mmol). The biphasic mixture was then stirred rapidly at 0 ˚C for 10 min, followed by transfer of the organic phase dropwise to a cooled solution (0 ˚C) of amine salt 11 (65 mg, 0.14 mmol) and Hunig's base (73 µl, 0.42 mmol) in DMF (1 ml) (previously stirred for 10 min). This mixture was then further stirred at this temperature for 1 hour, followed by removal of all solvents at high vacuum. The crude material was directly purified by column chromatography (9.5 CHCl 3 : 0. To a mixture of N-CBz belactosin A 20 (24 mg, 0.048 mmol) and Pd/C (24 mg), was added THF (1ml) and the mixture was thoroughly purged with H 2 until the solvent volume was approximately 0.30 ml. To this suspension was added formic acid (0.20 ml), and the mixture was placed under a balloon pressure of H 2 , and stirred at room temperature for 2.5 hours. The suspension was then filtered, washed with CH 2 Cl 2 (2 x 2 ml), and concentrated in vacuo. Distilled water was added (2 x 1 ml), and the dissolved filtrate was again filtered then concentrated at high vacuum. 3252, 3074, 2964, 1832, 1674, 1598, 1397, 1205, 1139, 911, 801, 723; (1) 
